These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 34340527

  • 1. A Phase-2 Pilot Study of a Therapeutic Combination of Δ9-Tetrahydracannabinol and Palmitoylethanolamide for Adults With Tourette's Syndrome.
    Bloch MH, Landeros-Weisenberger A, Johnson JA, Leckman JF.
    J Neuropsychiatry Clin Neurosci; 2021; 33(4):328-336. PubMed ID: 34340527
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T, Emrich HM.
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
    Yoo HK, Joung YS, Lee JS, Song DH, Lee YS, Kim JW, Kim BN, Cho SC.
    J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
    Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR.
    J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
    [Abstract] [Full Text] [Related]

  • 9. Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial.
    Welter ML, Houeto JL, Thobois S, Bataille B, Guenot M, Worbe Y, Hartmann A, Czernecki V, Bardinet E, Yelnik J, du Montcel ST, Agid Y, Vidailhet M, Cornu P, Tanguy A, Ansquer S, Jaafari N, Poulet E, Serra G, Burbaud P, Cuny E, Aouizerate B, Pollak P, Chabardes S, Polosan M, Borg M, Fontaine D, Giordana B, Raoul S, Rouaud T, Sauvaget A, Jalenques I, Karachi C, Mallet L, STIC study group.
    Lancet Neurol; 2017 Aug; 16(8):610-619. PubMed ID: 28645853
    [Abstract] [Full Text] [Related]

  • 10. Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial.
    Kefalopoulou Z, Zrinzo L, Jahanshahi M, Candelario J, Milabo C, Beigi M, Akram H, Hyam J, Clayton J, Kass-Iliyya L, Silverdale M, Evans J, Limousin P, Hariz M, Joyce E, Foltynie T.
    Lancet Neurol; 2015 Jun; 14(6):595-605. PubMed ID: 25882029
    [Abstract] [Full Text] [Related]

  • 11. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome.
    Abi-Jaoude E, Bhikram T, Parveen F, Levenbach J, Lafreniere-Roula M, Sandor P.
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329
    [Abstract] [Full Text] [Related]

  • 12. Ondansetron treatment in patients with Tourette's syndrome.
    Toren P, Laor N, Cohen DJ, Wolmer L, Weizman A.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):373-6. PubMed ID: 10565805
    [Abstract] [Full Text] [Related]

  • 13. Risperidone as a treatment for Tourette's syndrome.
    Bruun RD, Budman CL.
    J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544
    [Abstract] [Full Text] [Related]

  • 14. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
    Lyon GJ, Samar S, Jummani R, Hirsch S, Spirgel A, Goldman R, Coffey BJ.
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
    [Abstract] [Full Text] [Related]

  • 15. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.
    Budman CL, Gayer A, Lesser M, Shi Q, Bruun RD.
    J Clin Psychiatry; 2001 Apr; 62(4):290-4. PubMed ID: 11379844
    [Abstract] [Full Text] [Related]

  • 16. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome.
    Kurlan R, Crespi G, Coffey B, Mueller-Vahl K, Koval S, Wunderlich G, Pramipexole for TS Trial Investigators.
    Mov Disord; 2012 May; 27(6):775-8. PubMed ID: 22407510
    [Abstract] [Full Text] [Related]

  • 17. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
    Gabbay V, Babb JS, Klein RG, Panzer AM, Katz Y, Alonso CM, Petkova E, Wang J, Coffey BJ.
    Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
    [Abstract] [Full Text] [Related]

  • 18. Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.
    Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR.
    Neurology; 2000 Mar 28; 54(6):1310-5. PubMed ID: 10746603
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoids for Tourette's Syndrome.
    Curtis A, Clarke CE, Rickards HE.
    Cochrane Database Syst Rev; 2009 Oct 07; 2009(4):CD006565. PubMed ID: 19821373
    [Abstract] [Full Text] [Related]

  • 20. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
    Stephens RJ, Bassel C, Sandor P.
    J Child Adolesc Psychopharmacol; 2004 Oct 07; 14(2):255-66. PubMed ID: 15319022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.